DAGL drug
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| DAGL | regulates | 2-AG | — | 2 |
| DAGL | regulates | depolarization-induced suppression of inhibition | — | 1 |
Mentioned in (4)
Papers in which this entity is mentioned.
- Prenatal drug exposure and neurodevelopmental programming of glucocorticoid signalling. (2020)
- CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function. (2016)
- Cannabis and psychosis/schizophrenia: human studies. (2009)
- Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. (2009)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| dagl | drug | 2 | 2 |
| diacylglycerol lipase | drug | 2 | 2 |
| α-diacylglycerol lipase | drug | — | — |
| β-diacylglycerol lipase | drug | — | — |